However, the discovery that specific monogenic mutations, e.g. mutations in the SNCA gene (encoding α-synuclein), cause genetic forms of PD has contributed markedly to the understanding of the molecular mechanisms of PD pathogenicity [1–3]. This evidence concerns the gene SNCA and Parkinson disease.